The Borderless Clinic: How AI Globalizes the Knowledge Economy
Last Tuesday, a patient sat across from me and slid a thin stack of outside records onto the desk, the kind of stack that tells you the story has already been through three systems and two time zones. She had seen a specialist while visiting family abroad, then another when she returned home, and now she wanted to know which recommendation actually belonged to her. I opened the chart, then opened an AI summary tool, and watched it pull together fragments that had never been written for one room, one country, or one doctor.
She looked at me and said, “So which doctor is right?”
I did not answer quickly. I was thinking about a different question, the one hiding inside hers. If medicine used to be local, bounded by a neighborhood, a license, a training pipeline, and a physical clinic, what happens when the cognitive machinery around medicine stops being local?
For years, I thought globalization mostly belonged to manufacturing, shipping, and finance. I knew medicine had some exceptions, medical tourism for the well resourced, second opinions for the determined, conferences where people swapped ideas over coffee. But the daily practice of care still felt stubbornly regional. Patients usually stayed inside their own health system. Clinicians mostly learned from their own institutions, their own journals, their own professional networks. Then AI arrived carrying something I had underestimated: the world’s knowledge, averaged, compressed, translated, and returned at bedside speed.
I call this the borderless clinic. It is a simple phrase, and it captures a hard fact. The model answering a question in my exam room may have been shaped by radiology reports from Seoul, pathology annotations from São Paulo, policy discussions in Geneva, code from Bengaluru, and clinical writing from Boston. The knowledge economy is globalizing through the training data itself, not just through trade, travel, or institutions.
The Knowledge Economy Has Moved Under Our Feet
Most people understand globalization as the movement of goods. The more unsettling version is the movement of judgment. AI does not merely distribute information faster. It recombines the intellectual labor of millions of people, many of whom will never know their contributions were part of the final system. That matters because knowledge work has long been protected by geography in a way factory work was not. A physician in one city did not easily compete with a physician in another. A lawyer, editor, analyst, or engineer usually lived inside a local market with local norms and local clients.
AI weakens those boundaries. In a 2026 analysis, Agentic AI and Occupational Displacement: A Multi-Regional Task Exposure Analysis of Emerging Labor Market Disruption describes how exposure to AI is not evenly distributed and how task displacement varies by region and occupation. The point is larger than labor economics. Once cognitive work becomes machine-mediated, the old advantage of being the person in the room matters less than being the person who can direct, verify, and interpret a globally trained system.
That is why the physician’s role changes first. I am not just using a tool. I am supervising an intelligence that was assembled from a transnational archive of human work. The clinic is becoming a border crossing.
And there is a second layer. Training data crosses borders even when companies do not. Clinical notes, journal articles, public datasets, code repositories, images, and policy texts all circulate internationally. The result is a new kind of imported expertise, one that is not stamped by customs but is still shaped by power. The systems that feel local at the point of use are built on a global substrate.
What I Used to Believe, and Why I Changed
I used to believe that AI would mainly flatten expertise inside wealthy countries. My worry was obvious enough, automation, deskilling, the erosion of professional judgment, the usual anxieties that show up whenever software gets smarter. Then I saw something else in practice. The real destabilization was not just downward within a country. It was outward across borders.
A colleague once told me, after a difficult case conference, “The model gave a decent answer, but it sounded like it had read every good textbook in the world.” That line stayed with me because it named the change more clearly than any policy memo. The competitive unit is no longer the single practitioner or even the single institution. It is the global knowledge stack underneath the practitioner.
I now think the uncomfortable truth is this: AI globalizes the knowledge economy in the same way container shipping globalized manufacturing. It turns local scarcity into networked abundance, then redistributes value away from the people who used to own the bottleneck. For manufacturing, the bottleneck was physical production. For knowledge work, the bottleneck is increasingly synthesis.
There is evidence that clinicians sense this shift even if they do not name it that way. In the mixed-methods physician survey reported in Journal of Medical Internet Research (2025), 498 physicians reported that AI could speed routine tasks in 83.1% of responses, while 82.5% worried about liability and 75.7% worried about transparency. Those numbers tell me something important. Physicians are not afraid only of bad models. They are afraid of losing control over a knowledge pipeline that is already moving faster than traditional professional oversight.
The Global Majority Is Already Inside the Model
The most common mistake in AI commentary is to talk as if the model belongs to one country, one company, or one language. It does not. The model is built from a global fund of knowledge, and the people whose work feeds it are often far removed from the markets that profit from it.
The Global Majority in International AI Governance argues that rule-making power remains concentrated in a small set of countries and institutions, while the people most affected by AI’s spread have the least influence over its norms. I think that matters clinically because medicine already understands the harms of asymmetric decision-making. If a treatment protocol is built without the population it is meant to serve, outcomes suffer. AI governance is starting to look the same way.
One of the clearest examples is language. A model that performs well in English and poorly in other languages is not neutral. It is a map of global inequality with a friendly interface. The same is true for health. A system trained largely on data from high-resource settings may produce elegant answers and still fail when it meets the mess of real-world care in under-resourced clinics, multilingual communities, or health systems with different disease prevalence.
The deeper issue is that the model’s “knowledge” is not just technical. It reflects which patients were documented, which clinicians had time to write, which institutions had digitized archives, which countries could contribute compute, and which legal regimes allowed data reuse. That is globalization by accumulation, not by consent.
I do not romanticize the old local model. Local expertise has always excluded people, especially those outside elite institutions. But I also do not accept the fantasy that globalized AI automatically democratises knowledge. Access to a global model is not the same as shared authorship of the model. Those are different moral claims.
What I Would Not Do
I would not hand a model authority over diagnosis, triage, prescribing, or prognosis without a named clinician accountable for the final decision. I would not deploy AI as a silent authority that drafts the answer while hiding the source of the reasoning. I would not accept a system whose outputs cannot be audited when the stakes include a missed cancer, a delayed sepsis workup, or a falsely reassuring discharge plan.
That is the professional line I keep. Not because I distrust every model, but because I trust workflows less than I trust people. Workflows can hide failure very efficiently.
The 2025 survey literature reflects that same unease. Physicians were broadly optimistic, yet concerns about liability and transparency were dominant. In my experience, those concerns are not abstract. They show up when an AI summary misses a medication change from a hospital abroad, or when a translated note collapses nuance that matters to the treatment plan. The failure is often mundane. That is what makes it dangerous.
The Borderless Clinic Has Winners and Losers
The obvious winners are the people and organizations that can sit on top of the new global knowledge layer. They can ask better questions, move faster, and scale expertise without hiring at the old rate. The less obvious winners are patients, if and only if clinicians remain engaged enough to catch the model when it drifts.
The likely losers are the knowledge workers who built their insulation around local scarcity. Some of that will be physician-only. Some of it will be shared with lawyers, teachers, analysts, radiologists, editors, and researchers. AI does not erase expertise. It changes the market price of parts of expertise.
This is where the metaphor of manufacturing becomes useful. Manufacturing did not vanish in the United States because people stopped needing products. It changed because the location of production changed. Knowledge work is now facing a similar pressure. The value migrates toward those who can curate, verify, and integrate global inputs, and away from those who simply possess information once treated as scarce.
A 2026 paper on occupational exposure to AI argues that the risk is uneven across tasks and regions. That unevenness is the story. AI will not hit every profession the same way, and it will not hit every country the same way. Some health systems will use it to widen access to expertise. Others will use it to concentrate influence and export dependence.
Why Medicine Matters Here
Medicine is a useful lens because it is both local and global at once. A patient’s body is singular. The evidence base is collective. I can only care for the person in front of me, but I depend on a knowledge system built by people I will never meet. AI intensifies that dependence while making it look effortless.
In that sense, medicine previews the future of the entire knowledge economy. The physician is becoming a kind of interpreter between local suffering and global cognition. I think that role will survive, but only if we defend it. The profession has to insist on verification, transparency, and human accountability. We also have to accept that our own authority is now porous, shaped by systems whose inputs come from outside our borders and sometimes outside our awareness.
The best evidence we have suggests that physicians are ready for assistance and wary of surrender. A 2025 study of physician attitudes toward medical AI found that 83.1% expected faster routine task processing, but 82.5% worried about liability and 75.7% worried about opacity. Those are not contradictory positions. They are the contours of mature skepticism.
I share that skepticism. I also share the hope. Because I have seen what happens when a model surfaces a rare diagnosis faster than I could have done alone, or when it compresses a messy chart into a usable clinical picture. The patient in front of me does not care which country contributed which token to the model. She cares whether the answer is careful, honest, and safe.
Returning to the Exam Room
After a few minutes, I turned back to the woman with the outside records and told her what I thought. I explained which recommendation fit the data, which one I would ignore, and which questions still needed human judgment. The AI summary had helped, but only because I treated it as a global assistant, not an oracle.
She nodded and said, “So it can help, but you still have to decide.”
Exactly.
That is the borderless clinic in one sentence. The model can gather the world’s knowledge, but the doctor still has to carry the responsibility of use. The knowledge economy is global now. Medicine is simply one of the first places where that fact becomes visible at the bedside.
For readers who want the clinician’s perspective behind this essay, I keep a short bio and background on Dr. Sina Bari, Stanford-trained surgeon, and I also write about medicine, practice, and the changing culture of care at sinabarimd.com.
FAQ
How does AI globalize the knowledge economy?
AI globalizes the knowledge economy by training on contributions from many countries, institutions, and languages, then packaging that knowledge for instant use anywhere. The result is that expertise becomes less tied to one geography and more tied to whoever can build, verify, and deploy the system.
What happens when a clinician uses AI trained on international data?
The main benefit is broader synthesis, because the system may reflect patterns, literature, and workflows from far beyond one hospital or country. The main risk is mismatch, since prevalence, language, documentation style, and care pathways can differ sharply across settings.
What would Dr. Sina Bari do differently with AI in clinical practice?
I would use AI as a second set of eyes, not as final authority. I would require visible sources, clinician review, and a workflow that makes it hard for a bad summary to pass as truth.
Can AI widen or narrow global inequality in medicine?
It can do both. If access is broad but authorship, compute, and governance stay concentrated, inequality widens. If models are audited, multilingual, and accountable to diverse health systems, they can reduce some access gaps.
Why are physicians worried about AI even when they like it?
Physicians often like the speed and support, but they worry about liability, transparency, and hidden failure modes. In the clinic, a confident wrong answer can be worse than no answer at all.